Return to content in this issue

 

Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels

Penella J1, Quan P1, Carvallo A1, Chopitea A2, Sala P2, García del Barrio MA3, Gastaminza G1, Goikoetxea MJ1

1Department of Allergy and Clinical Immunology. Clínica Universidad de Navarra. Pamplona. Spain
2Department of Oncology. Clínica Universidad de Navarra. Pamplona. Spain
3Department of Pharmacy. Clínica Universidad de Navarra. Pamplona. Spain

J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0496

Key words: Desensitization, Omalizumab, Oxaliplatin, Drugallergy